Latvia vs South Asia (IDA & IBRD): Immunization, HepB3
Latvia
99.0%
in 2024
South Asia (IDA & IBRD)
94.5%
in 2024
Latvia rank
1st
South Asia (IDA & IBRD) rank
1st
Immunization, HepB3 over time
- Latvia
- South Asia (IDA & IBRD)
How they compare
Latvia currently reports 99.0% against 94.5% in South Asia (IDA & IBRD), a difference of 4.5%.
Across all 28 years both countries report, Latvia has been ahead every year.
Latvia ranks 1st and South Asia (IDA & IBRD) ranks 1st of 188 countries.
Latvia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Latvia | South Asia (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 36.3% | 0.1% | 36.3% | Latvia |
| 2000s | 95.4% | 14.4% | 81.0% | Latvia |
| 2010s | 94.1% | 77.2% | 16.9% | Latvia |
| 2020s | 96.8% | 90.6% | 6.2% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Latvia or South Asia (IDA & IBRD)?
- Latvia, at 99.0% against 94.5% in South Asia (IDA & IBRD) as of 2024.
- What is the difference in immunization, hepb3 between Latvia and South Asia (IDA & IBRD)?
- 4.5%, with Latvia ahead.
- How many years of comparable data are there for Latvia and South Asia (IDA & IBRD)?
- 28 years are reported by both, from 1997 to 2024.
- How do Latvia and South Asia (IDA & IBRD) rank globally for immunization, hepb3?
- Latvia ranks 1st and South Asia (IDA & IBRD) ranks 1st of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.